Skip to main content
. 2018 Nov 30;2018(11):CD003177. doi: 10.1002/14651858.CD003177.pub4

MENU 2016.

Methods Metabolism, Exercise and Nutrition at UCSD (MENU)
RCT, parallel, (walnut rich moderate fat diet vs moderate fat diet), 12 months
Summary risk of bias: moderate or high
Participants Overweight and obese women, of whom half were insulin resistant
N: 82 intervention, 81 control (analysed, intervention: 65 control: 61)
Level of risk for CVD: low
Men: 0% intervention, 0% control
Mean age (SD) years: 51 (NR) intervention, 50 (NR) control
Age range: 22‐67 years intervention, 25‐72 years control
Smokers: not reported
Hypertension: not reported
Medications taken by at least 50% of those in the control group: not reported
Medications taken by 20%‐49% of those in the control group: not reported
Medications taken by some, but less than 20% of the control group: 10% were on cholesterol medications
Location: USA
Ethnicity: Hispanic 18% intervention, 14% control; black 9% intervention, 3% control; Asian American 1% intervention, 4% control; white non‐Hispanic 71% intervention, 78% control.
Interventions Type: food and advice
Comparison: walnut rich moderate fat diet (ALA) vs moderate fat diet (MUFA)
Intervention: advice to follow walnut‐rich higher fat diet (35%E fat with limited SFA, MUFA encouraged, including 42 g/d walnuts (provided by study), 45%E CHO, 20%E protein). Participants given print materials on diet and exercise, attended group sessions weekly for 1st 4 months, biweekly for next 2 months, then monthly to 1 year), provided web‐based tracking for dietary constituents, scale, pedometer, measuring cups and exercise videos. Regular dietetic and group leader support. Clinic visits were at 0, 6 and 12 months. Dose: ˜4.2 g/d ALA (calculated based on 42 g/d intake of walnuts)
Control: exactly as intervention for goals, materials and support except higher fat diet did not include walnuts (35% E fat with limited SFA, MUFA encouraged, 45%E CHO, 20%E protein)
Compliance: walnut consumption reported on form and nuts provided. Red blood cell ALA significantly higher in intervention at 12 months than control
Duration of intervention: 12 months
Outcomes Main study outcome: body weight
Dropouts: 13 of 82 intervention, 12 of 81 control
Available outcomes: weight, waist circumference, HDL and LDL cholesterol, triglycerides, insulin, glucose, HOMA‐IR, HOMA‐beta, CRP and IL‐6 (estradiol, SHBG, nutrient gene interactions, physical activity and heart rate also presented)
Response to contact: no reply received to date
Notes Study funding: National Cancer Institute and California Walnut Commission
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Randomisation stratified by age and insulin resistance
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Open study, participants were advised on their diets extensively
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Blinding not mentioned, so unclear for their primary outcome, weight
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Paper states ITT analysis but 25 dropouts (15%) not included in 1 year data, but dropout reasons clear
Selective reporting (reporting bias) Low risk Pre‐registered, all mentioned outcomes reported at 12 months
Attention Low risk Appear very equal
Compliance Low risk Statistically significant difference between intervention and control arms for ALA in blood cell membranes at 12 months
Other bias Low risk None noted
HHS Vulnerability Disclosure